On February 7, 2024 Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, reported that Company management will present at the following conferences in February 2024 (Press release, Sensei Biotherapeutics, FEB 7, 2024, View Source [SID1234639918]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
Wednesday, February 14, 2024, at 10:00 a.m. ET.
Virtual

10th Annual Immuno-Oncology 360 Conference (IO360)
Thursday, February 29, 2024, at 11:10 a.m. ET
Brooklyn, NY

A webcast of Sensei’s presentation at Oppenheimer will be available in the Investors section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event. Registration for the webcast is available here.